Coronavirus vaccine trump offers 1b to german firm

You're referring to the news about the COVID-19 vaccine development!

Yes, on July 22, 2020, President Donald Trump announced that the US government would provide $1 billion to a German biotech firm, CureVac, to develop a COVID-19 vaccine. The funding was part of a partnership between the US government and CureVac to accelerate the development of a vaccine against the coronavirus.

CureVac is a biotech company based in Tübingen, Germany, that specializes in mRNA-based vaccine technology. The company had already been working on a COVID-19 vaccine candidate, CVnCoV, which uses a modified mRNA molecule to encode a piece of the SARS-CoV-2 virus.

The $1 billion investment from the US government was intended to support the further development and testing of CVnCoV, with the goal of making it available for emergency use authorization (EUA) in the US and other countries. The funding was also expected to help CureVac scale up its manufacturing capacity to produce millions of doses of the vaccine.

It's worth noting that the US government has invested in several COVID-19 vaccine development programs, including those led by companies like Moderna, Johnson & Johnson, and Pfizer, among others. The goal is to develop multiple vaccines to combat the pandemic and ensure that there are enough doses available to protect the global population.